Sinopharm Group Co. Ltd. (HKG: 1099)
Hong Kong
· Delayed Price · Currency is HKD
20.20
-0.05 (-0.25%)
Nov 15, 2024, 4:08 PM HKT
Sinopharm Group Revenue
Sinopharm Group had revenue of 147.70B CNY in the quarter ending September 30, 2024, with 1.88% growth. This brings the company's revenue in the last twelve months to 593.07B, up 0.23% year-over-year. In the year 2023, Sinopharm Group had annual revenue of 596.57B with 8.05% growth.
Revenue (ttm)
593.07B CNY
Revenue Growth
+0.23%
P/S Ratio
0.10
Revenue / Employee
5.11M CNY
Employees
115,959
Market Cap
63.04B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
Dec 31, 2020 | 456.41B | 31.14B | 7.32% |
Dec 31, 2019 | 425.27B | 80.75B | 23.44% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSinopharm Group News
- 7 weeks ago - How AI and Sinopharm’s disruptive technologies are contributing to longer human life - The Times of India
- 3 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 3 years ago - Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines - Seeking Alpha
- 3 years ago - Diversifying Into Top-Ranked Sinopharm - Seeking Alpha
- 3 years ago - Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines - Seeking Alpha
- 4 years ago - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs - Seeking Alpha
- 4 years ago - 6 Stocks I Just Bought For My Retirement Portfolio - Hong Kong Edition - Seeking Alpha
- 4 years ago - Go Long On SinoPharm Group's HKEX Ticker 1099:HK - Seeking Alpha